StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
PartnershipJun 16, 2026, 08:32 AM

Microbot Medical Partners with Lovell for 2,000+ Gov Facility Access

AI Summary

Microbot Medical Inc. announced a vendor agreement with Lovell Government Services to expand access for its LIBERTY® Endovascular Robotic System. This partnership will enable the sale of the LIBERTY® System to over 2,000 U.S. government facilities, including those under the Veterans Health Administration, Military Health System, and Indian Health Service. Lovell Government Services will serve as the Company's Service-Disabled Veteran-Owned Small Business (SDVOSB) vendor, streamlining procurement and helping government agencies meet SDVOSB goals.

Key Highlights

  • Microbot Medical entered a vendor agreement with Lovell Government Services.
  • The agreement allows sales of the LIBERTY® Endovascular Robotic System to over 2,000 U.S. government facilities.
  • Target facilities include those administered by the U.S. Department of Veterans Affairs, Department of Defense, and Indian Health Service.
  • Lovell Government Services will act as the Company's Service-Disabled Veteran-Owned Small Business (SDVOSB) vendor.
  • The LIBERTY System will be added to Lovell's Federal Supply Schedule (FSS) contract, expected in Q3 2026.
  • The system will also be accessible via GSA Advantage, DLA ECAT, and DoD DAPA.
  • Lovell serves thousands of government care sites, including 170 medical centers averaging over 200 peripheral endovascular cases annually per site.